What is Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease primarily affecting the axial skeleton, characterized by bilateral sacroiliitis, inflammatory back pain, progressive spinal fusion through entheseal ossification, and a strong genetic association with HLA-B27 (present in 90-95% of patients). 1
Disease Classification and Spectrum
AS represents the most severe and radiographically advanced form within the axial spondyloarthritis (axSpA) spectrum. 2 The broader axSpA category encompasses:
- Radiographic axial SpA (classic AS): Definite structural changes visible on plain radiographs 2
- Non-radiographic axial SpA: Inflammatory changes detectable only on MRI without radiographic sacroiliitis 2
AS is distinguished from other spondyloarthropathies by universal sacroiliac joint involvement and higher propensity for complete spinal ankylosis. 2
Epidemiology
- Prevalence: 0.1-0.5% of the general population, with estimates including early forms ranging from 0.2-1.4% 1, 2
- Age of onset: Typically before age 45, often presenting in late adolescence or early adulthood 2
- Genetic predisposition: HLA-B27 positivity in 74-95% of AS patients, though only 1% of HLA-B27 carriers develop the disease 2, 1
Cardinal Clinical Features
Inflammatory Back Pain
The hallmark symptom, present in 70-80% of patients, with distinct characteristics: 2
- Insidious onset over weeks to months
- Improves with exercise but not with rest
- Worsens at night, particularly in the second half
- Morning stiffness of prolonged duration (>30 minutes) 1
- Alternating buttock pain from sacroiliitis 2
Pathologic Process
The disease follows a characteristic anatomic progression: 2
- Initial involvement: Bilateral sacroiliac joints (distinguishing AS from other spondyloarthropathies which may show unilateral involvement) 2
- Spinal progression: Ascending involvement, most commonly affecting thoracic spine and thoracolumbar junction 2
- Entheseal inflammation: Enthesitis, synovitis, and osteitis lead to bone erosion, sclerosis, and ultimately ossification 2
- End-stage: Complete ankylosis ("bamboo spine") with loss of spinal mobility 1
Extra-Articular Manifestations
Approximately 30-50% of AS patients develop peripheral involvement: 2
- Peripheral arthritis: Typically asymmetric, lower extremity predominant
- Enthesitis: Achilles tendon and plantar fascia most common 2
- Anterior uveitis: Most frequent extra-articular manifestation 3, 4
- Inflammatory bowel disease: Associated in subset of patients 4
- Cardiovascular: Aortitis, conduction abnormalities 4
- Pulmonary: Apical fibrosis in advanced disease 4
Diagnostic Challenges
A critical diagnostic delay of 4.9-7 years persists between symptom onset and diagnosis, highlighting the difficulty in early recognition. 2, 1 This delay occurs because:
- Inflammatory back pain symptoms are present in 5-15% of the general population, creating diagnostic noise 2
- Radiographic changes evolve slowly over years, with structural damage lagging behind symptoms by 7+ years 2
- Early disease may only show inflammatory changes on MRI without radiographic findings 2
Diagnostic Criteria Evolution
Modified New York Criteria (Historical)
Required radiographic sacroiliitis plus clinical criteria, missing patients in early disease stages. 2
ASAS Classification Criteria (Current)
Designed for research purposes, incorporates MRI findings to capture non-radiographic disease, though these criteria are not intended for definitive clinical diagnosis. 2
Disease Impact and Prognosis
Untreated entheseal inflammation progresses inexorably to fibrosis and ossification at affected sites, leading to: 1
- Functional decline: Progressive loss of spinal mobility and normal posture 2
- Work disability: Substantial interference with employment and daily activities 1
- Quality of life: Chronic pain, stiffness, and psychological burden 2, 1
- Complications: Increased fracture risk from rigid, osteoporotic spine 3
Common Diagnostic Pitfalls
- Dismissing young adults with chronic back pain as having mechanical causes without screening for inflammatory features 2
- Waiting for radiographic changes before considering the diagnosis, missing the 7-year window for early intervention 2
- Failing to recognize that HLA-B27 negativity does not exclude AS (present in 5-26% of AS patients) 2
- Overlooking extra-articular manifestations (uveitis, IBD) that may precede or accompany axial symptoms 4